Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Alli Sparks Reevaluation Of OTC Weight-Loss Indication

Feb 06 2006

• By Katia Fowler

Related Content

Short-Term Xenical Treatment Benefits “Difficult To Define,” FDA Says

Jan 23 2006

Decreased Supplement Use For Weight Loss Possible OTC Orlistat Benefit

Jan 30 2006

Alli Makes Passing Grade On Safety; Advisory Committee Debates Benefit

Jan 30 2006

Additional Topics

OTC Drugs Consumer

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window